Notices. Notice
180 words·~1 min read·
/register/2014/01/31/2014-01936·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 3710-08-P DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Filovirus Fusion Proteins and Their Uses AGENCY: Department of the Army, DoD. ACTION: Notice. SUMMARY: Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 13/882,041, entitled “Filovirus Fusion Proteins and Their Uses,” filed on April 26, 2013.
The United States Government, as represented by the Secretary of the Army, has rights to this invention. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012. FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney,
(301)619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA),
(301)619-6664, both at telefax
(301)619-5034. SUPPLEMENTARY INFORMATION: The invention relates to the use of the Filovirus glycoprotein fusion proteins for the prevention and diagnosis of Filovirus infection. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2014-01936 Filed 1-30-14; 8:45 am]